Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Concerns about the generic formulations of ADHD medications

Jolene Won
Meds
March 25, 2022
Share
Tweet
Share

I love generic brand products. I will fight to the last breath for my Shoppers’ Choice Adhesive Bandages rather than pay an extra $0.49 for Band-Aids. So why, then, have I been paying up to $395 every month for brand-name medication for the last two years instead of getting the generic version for $7.56? After all, aren’t generic drugs the same as their brand-name counterparts?

Let’s go back to November 2019, three months into my first year of medical school. I’m at the pharmacy picking up my monthly supply of Concerta, a task that has been a routine part of my life since I was diagnosed with ADHD at 15. When the clerk hands over the bottle of pills, I notice that the tablets are round instead of the barrel-shaped ones I’m used to. But I don’t think anything of it, because generic drugs are the same as brand-name, right? I just put the meds in my backpack, pay, and head back home.

That’s when the “off days” start. You know, when you wake up more tired than you went to bed, and the world looks a bit grayer, and inertia seems stronger than it used to. I chalk it up to seasonal affective disorder and buy myself a cheap light therapy lamp I can find on Amazon. It doesn’t really help, but my suspicions seem to be confirmed anyways when I return home to California for winter break and feel better almost instantly. I don’t give a second thought to the barrel-shaped tablets I pick up from my home pharmacy.

The new semester starts, and I am just settling back into my life in Chicago when COVID-19 sweeps into town and stops the entire world. I’ve never had trouble summoning the energy to feed myself or get out of bed before, but then again, I’ve never lived in a world where cities have to load their dead into ice rinks because the morgues are full. It seems reasonable to feel a little down, and then a little more. To wish everything would just … stop.

When lockdowns begin, I return to California to shelter in place with my partner and his dog – but I still don’t feel better. I’ve lost more than 10 percent of my body weight, leaving me at 5′ 7″ and 108 pounds. And as summer arrives, restrictions start to lift, and the world starts to come back to life again, I find myself Googling how to tie a noose. The internet reminds me that there is no reliable, considerate way to commit suicide, and I feel even more trapped than I did when lockdown first began.

But then, on one May morning, I’m halfheartedly preparing for Zoom class when I reach for my Concerta and promptly knock it off the bathroom shelf. There are only a couple pills left inside, so it topples and bounces right into my still half-full suitcase. I pause, unsure if I care enough to retrieve it, before remembering this month’s refill, which I’d just picked up yesterday and is still in my purse. When I pull the bottle out, I’m surprised to see the barrel-shaped brand-name pills. But of course, it doesn’t matter – right? Shrugging, I pop a pill and head back to my laptop.

For the first time in a long time, class is fun. I have the energy to stay engaged, and I feel like I have things to contribute. Outside, the sun is shining; the weather has been clear for weeks, but today, I notice. I don’t think about dying at all. And the next day is the same, and the next. After three days, an idea takes root in my brain. I fish out the old bottle from my suitcase and take one of the remaining generic pills. Just as I suspected, I sleepwalk through the entire day, feeling like there’s a ball of lead suspended behind my ribcage. The next day, I switch back to the brand-name pills, and the weight disappears again.

Like any millennial, I take to the internet to investigate further, and that’s where I stumble upon author Gina Pera’s blog ADHD Roller Coaster. Pera, the author of Is It You, Me, or Adult A.D.D?, has been writing about the ADHD community’s concerns surrounding generic formulations of Concerta since 2011. Her reporting sends me down a rabbit hole of pharmacokinetics and legislative red tape that I’d never known existed – even as a medical student.

According to the FDA, the area under the curve of the plasma drug concentration over time, which reflects drug exposure, can range from 80 to 125 percent of the brand-name medication. Generics also don’t need to have the same delivery systems as their branded counterparts either – which is particularly striking in the case of Concerta, which is differentiated from the chemically identical Ritalin XR by a unique osmotic release mechanism.

Unsurprisingly, multiple studies have found that switching from brand-name to generic Concerta caused significant adverse effects. The bioequivalence ratings of at least two generic formulations have been downgraded by the FDA after evidence emerged that they delivered the drug at an inadequate rate, thanks to lobbying by Ms. Pera and other ADHD advocates. Even more alarmingly, this phenomenon is not limited to a tiny subset of patients on this specific medication. Branded formulations of antidepressants and antiepileptics have also been associated with better clinical outcomes when compared to their generic counterparts.

I’ve only taken brand-name Concerta for almost two years now, and I haven’t thought about killing myself ever since. I am still a ride-or-die generics supporter in most ways; I’ll happily take the generic ciprofloxacin prescribed for my infected cartilage piercing, or pop a Daily Value loratadine when my seasonal allergies act up. But I was fortunate enough to be able to figure out what was happening to me. I had doctors who believed me and were willing to work with me to help me get the branded formulation of my Concerta. I’ve had the resources to afford the exorbitant fees my insurance charges for opting for a brand name instead of a generic. I want to share my experiences for the patients out there who aren’t as lucky, and for providers who want to do right by them.

Jolene Won is a medical student.

Image credit: Shutterstock.com

ADVERTISEMENT

Prev

We're failing people with opioid use disorder [PODCAST]

March 24, 2022 Kevin 0
…
Next

Financial infidelity: It's not about the money, it's about trust

March 25, 2022 Kevin 0
…

Tagged as: Medications, Psychiatry

Post navigation

< Previous Post
We're failing people with opioid use disorder [PODCAST]
Next Post >
Financial infidelity: It's not about the money, it's about trust

ADVERTISEMENT

Related Posts

  • The ritual of taking medications: the pill wheel

    Fery Pashang, PharmD
  • How hospitals can impact generic drug companies

    Mark Kelley, MD
  • Tips to help you afford medications

    Roy Benaroch, MD
  • An innovative approach to fix the generic drug shortage

    Christopher Johnson, MD
  • The double-edged power of the medications we prescribe

    Hans Duvefelt, MD
  • How can we improve the quality of medications?

    J. Leonard Lichtenfeld, MD

More in Meds

  • Why kratom addiction is the next public health crisis

    Muhamad Aly Rifai, MD
  • FDA delays could end vital treatment for rare disease patients

    GJ van Londen, MD
  • Pharmacists are key to expanding Medicaid access to digital therapeutics

    Amanda Matter
  • How medicine repurposing enables value-based pain management and insomnia therapy

    Olumuyiwa Bamgbade, MD
  • Forced voicemail and diagnosis codes are endangering patient access to medications

    Arthur Lazarus, MD, MBA
  • From stigma to science: Rethinking the U.S. drug scheduling system

    Artin Asadipooya
  • Most Popular

  • Past Week

    • Why primary care doctors are drowning in debt despite saving lives

      John Wei, MD | Physician
    • How federal actions threaten vaccine policy and trust

      American College of Physicians | Conditions
    • Are we repeating the statin playbook with lipoprotein(a)?

      Larry Kaskel, MD | Conditions
    • mRNA post vaccination syndrome: Is it real?

      Harry Oken, MD | Conditions
    • AI isn’t hallucinating, it’s fabricating—and that’s a problem [PODCAST]

      The Podcast by KevinMD | Podcast
    • Closing the diversity gap in Parkinson’s research

      Vicky Chan | Conditions
  • Past 6 Months

    • COVID-19 was real: a doctor’s frontline account

      Randall S. Fong, MD | Conditions
    • Why primary care doctors are drowning in debt despite saving lives

      John Wei, MD | Physician
    • Why so many doctors secretly feel like imposters

      Ryan Nadelson, MD | Physician
    • Confessions of a lipidologist in recovery: the infection we’ve ignored for 40 years

      Larry Kaskel, MD | Conditions
    • A physician employment agreement term that often tricks physicians

      Dennis Hursh, Esq | Finance
    • Why taxing remittances harms families and global health care

      Dalia Saha, MD | Finance
  • Recent Posts

    • AI isn’t hallucinating, it’s fabricating—and that’s a problem [PODCAST]

      The Podcast by KevinMD | Podcast
    • Brooklyn hepatitis C cluster reveals hidden dangers in outpatient clinics

      Don Weiss, MD, MPH | Policy
    • The truth in medicine: Why connection matters most

      Ryan Nadelson, MD | Physician
    • New student loan caps could shut low-income students out of medicine

      Tom Phan, MD | Physician
    • Why trust and simplicity matter more than buzzwords in hospital AI

      Rafael Rolon Rivera, MD | Tech
    • Putting food allergy safety on the menu [PODCAST]

      The Podcast by KevinMD | Podcast

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Why primary care doctors are drowning in debt despite saving lives

      John Wei, MD | Physician
    • How federal actions threaten vaccine policy and trust

      American College of Physicians | Conditions
    • Are we repeating the statin playbook with lipoprotein(a)?

      Larry Kaskel, MD | Conditions
    • mRNA post vaccination syndrome: Is it real?

      Harry Oken, MD | Conditions
    • AI isn’t hallucinating, it’s fabricating—and that’s a problem [PODCAST]

      The Podcast by KevinMD | Podcast
    • Closing the diversity gap in Parkinson’s research

      Vicky Chan | Conditions
  • Past 6 Months

    • COVID-19 was real: a doctor’s frontline account

      Randall S. Fong, MD | Conditions
    • Why primary care doctors are drowning in debt despite saving lives

      John Wei, MD | Physician
    • Why so many doctors secretly feel like imposters

      Ryan Nadelson, MD | Physician
    • Confessions of a lipidologist in recovery: the infection we’ve ignored for 40 years

      Larry Kaskel, MD | Conditions
    • A physician employment agreement term that often tricks physicians

      Dennis Hursh, Esq | Finance
    • Why taxing remittances harms families and global health care

      Dalia Saha, MD | Finance
  • Recent Posts

    • AI isn’t hallucinating, it’s fabricating—and that’s a problem [PODCAST]

      The Podcast by KevinMD | Podcast
    • Brooklyn hepatitis C cluster reveals hidden dangers in outpatient clinics

      Don Weiss, MD, MPH | Policy
    • The truth in medicine: Why connection matters most

      Ryan Nadelson, MD | Physician
    • New student loan caps could shut low-income students out of medicine

      Tom Phan, MD | Physician
    • Why trust and simplicity matter more than buzzwords in hospital AI

      Rafael Rolon Rivera, MD | Tech
    • Putting food allergy safety on the menu [PODCAST]

      The Podcast by KevinMD | Podcast

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...